Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical receives Nasdaq notice over $2.5 million stockholders' equity requirement

Negative Impact 5 of 5 legal/regulatory Written later

Adagio Medical Holdings received a Nasdaq deficiency letter on August 13, 2026, saying it does not meet the minimum $2,500,000 stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company reported stockholders' equity of $(415,000) in its June 30, 2026 quarterly report, and the notice has no immediate effect on its listing. Shareholders should note the company must submit a compliance plan by September 28, 2026, and the company's filing cites going concern and financing risks.

Key points

  • Nasdaq notice received August 13, 2026 for stockholders' equity below $2,500,000 minimum
  • Reported stockholders' equity of $(415,000) in Form 10-Q for period ended June 30, 2026
  • Compliance plan due by September 28, 2026; Staff may grant up to 180 calendar days to regain compliance if plan is accepted
  • Company does not meet alternative standards of $35 million market value of listed securities or $500,000 net income

The filing

CompanyAdagio Medical Holdings, Inc. (ADGM)
Form8-K, current report
Filed with the SECAug 14, 2026, 4:31 PM ET
Accession number0001104659-26-097242

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.